Table 4

Catalogue of barriers to genetic literacy, referral, and counselling, as identified by surgeons within included studies

Study numberBarriersType of barrier
2Ease of insurance approval, ease of referral to a genetic counsellor, and patient complianceSystem, patient
a) Ease of insurance approval “is burdensome, but we get it done,” according to 58% of surgeons; 26% felt it was “easy and straightforward” to obtain insurance approval of genetic testing for their patients, 9% considered insurance “too burdensome for us to deal with in our setting,” and 7% said approval was “often denied”
b) Ease of referral to a genetic counsellor: 51% reported easy local access, 17% provided own clinic counselling, 3% consulted genetic counsellor by telephone, 16% felt it was a “burdensome” process, 14% felt local access was “inadequate”
c) Patient compliance with genetic counsellor appointment: 61% reported patients attend appointment > 50% of time, and 22% reported their patients fail to keep appointments > 50% of time
3Survey respondents suggest changes to Ontario cancer genetics program: increased provider education and awareness, and public awareness; broadened criteria for access; increased provider autonomy (i.e., order genetic tests themselves); and increased access, availability, and resources (rural, timeliness, more clinics)System
a) 40% of surgeons and 56% of surgical oncologists are satisfied with availability of cancer genetics clinics in area
b) 39% of surgeons and 18% of surgical oncologists are satisfied with timeliness of referral appointments with cancer genetics clinics
c) 23% of surgeons and 6% of surgical oncologists are satisfied with timeliness of genetic testing results
d) 68% of surgeons and 69% of surgical oncologists are satisfied with quality of the referral letters from genetic counsellors
4Lack of time during busy clinicsSurgeon
5Decision of which provider should order genetic testing for incorporating testing in multidisciplinary careSurgeon
9Little contact between interprofessional teams impede communication about mainstreaming (i.e., surgeons and clinical genetics teams rarely met and did not know each other well)Surgeon, system
Lack of comprehensive guidelines detailing how patients should be managed
14Variation in surgeon attitude about genetic testing and counselling associated with receipt of genetic testing after breast cancer diagnosisSurgeon
16Poor understanding of the current guidelines among clinicians and variable clinical pathways for patients; also, a perception that another unspecified clinician is undertaking this workSurgeon, system